GULBAHAR ASRANOVA: Open Payments
NPI 1417672585 · HOFFMAN ESTATES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $215 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $156 |
| Madrigal Pharmaceuticals | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $112 |
| Boston Scientific Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
Products named: BREZTRI, REZDIFFRA, JARDIANCE, Bulkamid, VRAYLAR, MOUNJARO, AIRSUPRA, FARXIGA.
Industry payments across IL — which companies pay providers there.
